Analysts’ Viewpoint
Several key factors are reshaping the industry landscape of the North America cosmetic surgery market. Increase in societal acceptance of cosmetic procedures and emphasis on personal aesthetics are primary factors fueling the North America cosmetic surgery market size.
Changing beauty standards and the influence of social media contribute to the surge in demand for cosmetic enhancements, particularly among younger demographics.
The ongoing trend of minimally invasive procedures and continuous technological innovations, are likely to drive market growth. Furthermore, integration of digital tools for virtual consultations and treatment simulations enhance patient engagement and is a key North America cosmetic surgery market trend.
Increase in focus on personalized treatment plans, catering to the evolving preferences of a diverse patient population is likely to propel market progress.
The North America cosmetic surgery market is experiencing dynamic growth, driven by a convergence of factors reshaping the beauty landscape. Societal acceptance of cosmetic procedures has surged, fueled by evolving beauty standards and the influence of social media. Advancements in medical technologies and surgical techniques, has fueled the demand for aesthetic enhancements.
The region's well-established healthcare infrastructure and a pool of skilled plastic surgeons offer lucrative opportunities for market expansion. Increase in disposable incomes and a heightened emphasis on personal appearance are further market catalysts. Overall, the North America cosmetic surgery market stands as a dynamic and evolving industry at the intersection of healthcare and aesthetics.
People in North America are becoming more receptive to improving their appearance through cosmetic procedures as cultural views and beauty standards change. Opinions of beauty are greatly influenced by the media, especially social media platforms, which in turn influence decisions to seek cosmetic surgery in order to attain the desired aesthetics.
Modern medicine and technological developments have made cosmetic surgery safer, widely available, and more efficient. By being transparent about their cosmetic enhancements on social media, celebrities and influencers help to lessen the stigma attached to these procedures and encourage a wider range of people to think about aesthetic interventions.
The International Society of Aesthetic Plastic Surgery (ISAPS) reports that liposuction maintained its position as the most popular surgical procedure in 2022. The popularity of body contouring procedures is highlighted by the 21.1% increase in liposuction procedures. Liposuction, breast augmentation, eyelid surgery, abdominoplasty, and breast lift were the top five surgical procedures.
In terms of non-surgical procedures, the ISAPS report emphasizes the use of hyaluronic acid and botulinum toxin treatments. The general need for aesthetic interventions is greatly influenced by these non-invasive techniques, which are frequently utilized for wrinkle reduction and facial rejuvenation.
Among the most popular non-surgical procedures were hair removal and chemical peels, with chemical peels surpassing non-surgical skin tightening in the top five. All these factors are expected to boost the North America cosmetic surgery market value.
The North America cosmetic surgery market segmentation in terms of procedure type includes invasive procedures, and non-invasive procedures.
The non-invasive procedures segment held significant market share in 2022. Growth in demand for cosmetic enhancements with minimal downtime and lower associated risks such as injectable options, laser therapies, and non-surgical body contouring procedures, are leading to expansion of this segment.
Patients increasingly favor non-surgical options for facial rejuvenation, wrinkle reduction, and body contouring. The accessibility and convenience offered by non-invasive procedures align with the preferences of a broad demographic, including those seeking subtle enhancements and younger individuals entering the cosmetic market.
Technological advancements, such as advanced dermal fillers, energy-based devices, and laser technologies, continually enhance the efficacy and safety of non-invasive procedures and are boosting the North America cosmetic surgery market share.
The dominance of non-invasive procedures is expected to persist, driven by expanding patient awareness, and a societal shift toward embracing less invasive approaches for cosmetic enhancements in North America.
As per the North America cosmetic surgery market analysis, based on end-user, the hospitals and clinics segment is projected to account for major share during the forecast period. Hospitals, equipped with advanced surgical facilities and multidisciplinary teams, are preferred for complex and extensive cosmetic procedures.
The credibility and comprehensive medical support offered by hospitals attract patients seeking a holistic approach to cosmetic surgery.
On the other hand, cosmetic clinics cater to a growing demand for minimally invasive procedures and outpatient services. Their accessibility, shorter waiting times, and emphasis on convenience appeal to individuals seeking non-surgical interventions such as injectable or laser treatments.
This underscores a dual strategy within the market, where hospitals cater to intricate surgical interventions, and clinics cater to the burgeoning demand for less invasive procedures, collectively contributing to the North America cosmetic surgery market value.
According to the latest North America cosmetic surgery market forecast, the United States is the dominant country in the region. A combination of economic prosperity, and advanced healthcare infrastructure is driving market dynamics in the country.
Further, evolving beauty standards, strong emphasis on personal appearance, and influence of celebrity culture contribute to the high demand for cosmetic procedures.
The U.S. boasts a pool of skilled plastic surgeons, state-of-the-art medical facilities, and a regulatory environment conducive to innovation. Major metropolitan areas such as Los Angeles, New York, and Miami serve as epicenters for cosmetic surgery practices, attracting patients both domestically and internationally.
The North America cosmetic surgery market is consolidated, with the presence of a limited number of leading players. Expansion of product portfolio and mergers & acquisitions are the key strategies implemented by leading players.
Johnson & Johnson, AbbVie, Inc., Bausch Health Companies Inc., Cutera, Inc., Merz North America, Inc., Galderma Laboratories, L.P, Sientra, Inc., Apyx Medical, and Long Island Plastic Surgical Group are the prominent North America cosmetic surgery market manufacturers.
Each of these players has been profiled in the North America cosmetic surgery market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size Value in 2022 | US$ 16.2 Bn |
| Market Forecast Value in 2031 | More than US$ 29.2 Bn |
| Growth Rate (CAGR) | 6.8% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 16.2 Bn in 2022
It is projected to reach more than US$ 29.2 Bn by the end of 2031
The CAGR is anticipated to be 6.8% from 2023 to 2031
Advancements in technology, such as minimally invasive procedures, robotic surgery, and use of advanced imaging techniques
Based on procedure type, the non-invasive procedures segment accounted for more than 53% share in 2022
The U.S. is expected to account for the largest share from 2023 to 2031
Johnson & Johnson, AbbVie, Inc., Bausch Health Companies Inc., Cutera, Inc., Merz North America, Inc., Galderma Laboratories, L.P, Sientra, Inc., Apyx Medical, and Long Island Plastic Surgical Group
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: North America Cosmetic Surgery Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. North America Cosmetic Surgery Market Analysis and Forecasts, 2017 - 2031
5. Key Insights
5.1. Top Overall Cosmetic and Reconstructive Procedures
5.2. Most Performed Surgical Cosmetic Procedures in the United States in 2022
5.3. Surgical & Non-surgical Highlights in United States by Type
5.4. Technological Advances in Cosmetic Surgery
5.5. Covid Impact Analysis
6. North America Cosmetic Surgery Market Analysis and Forecasts, By Procedure Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Procedure Type, 2017 - 2031
6.3.1. Invasive Procedures
6.3.1.1. Breast augmentation
6.3.1.2. Liposuction
6.3.1.3. Nose reshaping
6.3.1.4. Eyelid Surgery
6.3.1.5. Tummy tuck
6.3.1.6. Others
6.3.2. Non-invasive Procedures
6.3.2.1. Botox injections
6.3.2.2. Soft tissue fillers
6.3.2.3. Chemical peel
6.3.2.4. Laser hair removal
6.3.2.5. Microdermabrasion
6.4. Market Attractiveness By Procedure Type
7. North America Cosmetic Surgery Market Analysis and Forecasts, By Gender
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Gender, 2017 - 2031
7.3.1. Female
7.3.2. Male
7.4. Market Attractiveness By Gender
8. North America Cosmetic Surgery Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 - 2031
8.3.1. Ambulatory Surgical Facilities
8.3.2. Hospitals and Clinics
8.3.3. Physician Offices and Cosmetic Centers
8.4. Market Attractiveness By End-user
9. North America Cosmetic Surgery Market Analysis and Forecasts, By Country
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. United States
9.2.2. Canada
9.3. Market Attractiveness By Country/Region
10. United States Cosmetic Surgery Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Procedure Type, 2017 - 2031
10.2.1. Invasive Procedures
10.2.1.1. Breast augmentation
10.2.1.2. Liposuction
10.2.1.3. Nose reshaping
10.2.1.4. Eyelid Surgery
10.2.1.5. Tummy tuck
10.2.1.6. Others
10.2.2. Non-invasive Procedures
10.2.2.1. Botox injections
10.2.2.2. Soft tissue fillers
10.2.2.3. Chemical peel
10.2.2.4. Laser hair removal
10.2.2.5. Microdermabrasion
10.3. Market Value Forecast By Gender, 2017 - 2031
10.3.1. Female
10.3.2. Male
10.4. Market Value Forecast By End-user, 2017 - 2031
10.4.1. Ambulatory Surgical Facilities
10.4.2. Hospitals and Clinics
10.4.3. Physician Offices and Cosmetic Centers
10.5. Market Attractiveness Analysis
10.5.1. By Procedure Type
10.5.2. By Gender
10.5.3. By End-user
11. Canada Cosmetic Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Procedure Type, 2017 - 2031
11.2.1. Invasive Procedures
11.2.1.1. Breast augmentation
11.2.1.2. Liposuction
11.2.1.3. Nose reshaping
11.2.1.4. Eyelid Surgery
11.2.1.5. Tummy tuck
11.2.1.6. Others
11.2.2. Non-invasive Procedures
11.2.2.1. Botox injections
11.2.2.2. Soft tissue fillers
11.2.2.3. Chemical peel
11.2.2.4. Laser hair removal
11.2.2.5. Microdermabrasion
11.3. Market Value Forecast By Gender, 2017 - 2031
11.3.1. Female
11.3.2. Male
11.4. Market Value Forecast By End-user, 2017 - 2031
11.4.1. Ambulatory Surgical Facilities
11.4.2. Hospitals and Clinics
11.4.3. Physician Offices and Cosmetic Centers
11.5. Market Attractiveness Analysis
11.5.1. By Procedure Type
11.5.2. By Gender
11.5.3. By End-user
12. Competition Landscape
12.1. Market Player – Competition Matrix (By Tier and Size of companies)
12.2. Market Share Analysis By Company (2022)
12.3. Company Profiles
12.3.1. Johnson & Johnson
12.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.1.2. Material Portfolio
12.3.1.3. Financial Overview
12.3.1.4. SWOT Analysis
12.3.1.5. Strategic Overview
12.3.2. Bausch Health Companies Inc.
12.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.2.2. Material Portfolio
12.3.2.3. Financial Overview
12.3.2.4. SWOT Analysis
12.3.2.5. Strategic Overview
12.3.3. Cutera, Inc.
12.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.3.2. Material Portfolio
12.3.3.3. Financial Overview
12.3.3.4. SWOT Analysis
12.3.3.5. Strategic Overview
12.3.4. Merz North America, Inc.
12.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.4.2. Material Portfolio
12.3.4.3. Financial Overview
12.3.4.4. SWOT Analysis
12.3.4.5. Strategic Overview
12.3.5. Galderma Laboratories, L.P
12.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.5.2. Material Portfolio
12.3.5.3. Financial Overview
12.3.5.4. SWOT Analysis
12.3.5.5. Strategic Overview
12.3.6. Sientra, Inc.
12.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.6.2. Material Portfolio
12.3.6.3. Financial Overview
12.3.6.4. SWOT Analysis
12.3.6.5. Strategic Overview
12.3.7. Apyx Medical
12.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.7.2. Material Portfolio
12.3.7.3. Financial Overview
12.3.7.4. SWOT Analysis
12.3.7.5. Strategic Overview
12.3.8. Long Island Plastic Surgical Group
12.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.8.2. Material Portfolio
12.3.8.3. Financial Overview
12.3.8.4. SWOT Analysis
12.3.8.5. Strategic Overview
12.3.9. AbbVie Inc.
12.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.9.2. Material Portfolio
12.3.9.3. Financial Overview
12.3.9.4. SWOT Analysis
12.3.9.5. Strategic Overview
List of Tables
Table 1: North America Cosmetic Surgery Market Value (US$ Mn) Forecast, 2017-2031
Table 2: North America Cosmetic Surgery Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 3: US Cosmetic Surgery Market Value (US$ Mn) Forecast, by Gender, 2017-2031
Table 4: US Cosmetic Surgery Market Value (US$ Mn) Forecast, by Procedure Type, 2017-2031
Table 5: US Cosmetic Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 6: Canada Cosmetic Surgery Market Value (US$ Mn) Forecast, by Gender, 2017-2031
Table 7: Canada Cosmetic Surgery Market Value (US$ Mn) Forecast, by Procedure Type, 2017-2031
Table 8: Canada Cosmetic Surgery Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: North America Cosmetic Surgery Market
Figure 02: North America Cosmetic Surgery Market Size (US$ Mn) Forecast, 2017-2031
Figure 03: Market Value Share, by Procedure Type (2022)
Figure 04: Market Value Share, by Gender (2022)
Figure 05: Market Value Share, by End-user (2022)
Figure 06: Market Value Share, by Region (2022)
Figure 07: North America Cosmetic Surgery Market Value Share, by Gender, 2022 and 2031
Figure 08 North America Cosmetic Surgery Market Attractiveness, by Gender, 2017-2031
Figure 09: North America Cosmetic Surgery Market Value Share, by Procedure Type, 2022 and 2031
Figure 10: North America Cosmetic Surgery Market Attractiveness, by Procedure Type, 2017-2031
Figure 11: North America Cosmetic Surgery Market Value Share, by End-user, 2022 and 2031
Figure 12: North America Cosmetic Surgery Market Attractiveness, by End-user, 2017-2031
Figure 13: North America Cosmetic Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 14: North America Cosmetic Surgery Market Value Share, by Country, 2017-2031
Figure 15: North America Cosmetic Surgery Market Attractiveness, by Country, 2017-2031
Figure 16: US Cosmetic Surgery Market Value Share, by Gender, 2022 and 2031
Figure 17: US Cosmetic Surgery Market Attractiveness, by Gender, 2017-2031
Figure 18: US Cosmetic Surgery Market Value Share, by Procedure Type, 2022 and 2031
Figure 19: US Cosmetic Surgery Market Attractiveness, by Procedure Type, 2017-2031
Figure 20: US Cosmetic Surgery Market Value Share, by End-user, 2022 and 2031
Figure 21: US Cosmetic Surgery Market Attractiveness, by End-user, 2017-2031
Figure 22: US Cosmetic Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 23: Canada Cosmetic Surgery Market Value Share, by Gender, 2022 and 2031
Figure 24: Canada Cosmetic Surgery Market Attractiveness, by Gender, 2017-2031
Figure 25: Canada Cosmetic Surgery Market Value Share, by Procedure, 2022 and 2031
Figure 26: Canada Cosmetic Surgery Market Attractiveness, by Procedure, 2017-2031
Figure 27: Canada Cosmetic Surgery Market Value Share, by Gender, 2022 and 2031
Figure 28: Canada Cosmetic Surgery Market Attractiveness, by Gender, 2017-2031
Figure 29: Canada Cosmetic Surgery Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
North America Cosmetic Surgery Market
